Related Experiment Video
Updated: Aug 7, 2025

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro
Published on: June 16, 2022
Proteolytic regulation of a galectin-3/Lrp1 axis controls osteoclast-mediated bone resorption
Lingxin Zhu1,2,3, Yi Tang2,3, Xiao-Yan Li2,3
1The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) and Key Laboratory of Oral Biomedicine Ministry of Education, School and Hospital of Stomatology, Wuhan University , Wuhan, China.
Abstract:
Bone-resorbing osteoclasts mobilize proteolytic enzymes belonging to the matrix metalloproteinase (MMP) family to directly degrade type I collagen, the dominant extracellular matrix component of skeletal tissues. While searching for additional MMP substrates critical to bone resorption, Mmp9/Mmp14 double-knockout (DKO) osteoclasts-as well as MMP-inhibited human osteoclasts-unexpectedly display major changes in transcriptional programs in tandem with compromised RhoA activation, sealing zone formation and bone resorption. Further study revealed that osteoclast function is dependent on the ability of Mmp9 and Mmp14 to cooperatively proteolyze the β-galactoside-binding lectin, galectin-3, on the cell surface. Mass spectrometry identified the galectin-3 receptor as low-density lipoprotein-related protein-1 (Lrp1), whose targeting in DKO osteoclasts fully rescues RhoA activation, sealing zone formation and bone resorption. Together, these findings identify a previously unrecognized galectin-3/Lrp1 axis whose proteolytic regulation controls both the transcriptional programs and the intracellular signaling cascades critical to mouse as well as human osteoclast function.
Insights
Matrix metalloproteinases (MMPs) regulate osteoclast function by degrading galectin-3. This process, involving the galectin-3 receptor Lrp1, is crucial for bone resorption and cellular signaling in both mice and humans.
Area of Science:
- Cell Biology
- Biochemistry
- Skeletal Biology
Background:
- Osteoclasts are critical for bone resorption, utilizing matrix metalloproteinases (MMPs) to degrade type I collagen.
- The precise substrates and regulatory mechanisms of MMPs in osteoclast function remain incompletely understood.
Purpose of the Study:
- To identify novel MMP substrates essential for osteoclast activity.
- To elucidate the molecular mechanisms by which MMPs regulate osteoclast-mediated bone resorption.
Main Methods:
- Utilized Mmp9/Mmp14 double-knockout (DKO) osteoclasts and MMP-inhibited human osteoclasts.
- Employed mass spectrometry to identify protein interactions and receptors.
- Assessed RhoA activation, sealing zone formation, and bone resorption assays.
Main Results:
- DKO and MMP-inhibited osteoclasts exhibited altered transcriptional programs, impaired RhoA activation, sealing zone formation, and bone resorption.
- Mmp9 and Mmp14 were found to cooperatively proteolyze cell surface galectin-3.
- Low-density lipoprotein-related protein-1 (Lrp1) was identified as the galectin-3 receptor, and its targeting rescued osteoclast function in DKO cells.
Conclusions:
- A novel galectin-3/Lrp1 axis regulates osteoclast function through proteolytic control.
- This pathway influences both transcriptional programs and intracellular signaling cascades vital for osteoclast activity in mice and humans.
Related Concept Videos
Osteoclasts in Bone Remodeling
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Amplifying Signals via Enzymatic Cascade
GPCRs Regulate Adenylyl Cylase Activity
Inducible Operons: lac Operon
Role of Matrix Metalloproteases in Degradation of ECM

